Search

Your search keyword '"Azuma, Yoko"' showing total 245 results
Start Over Author "Azuma, Yoko"
245 results on '"Azuma, Yoko"'

9. Risk-adjusted hazard analysis of survival after pulmonary metastasectomy for uterine malignancies in 319 cases

Author

Nobori, Yuya, Anraku, Masaki, Yamauchi, Yoshikane, Mun, Mingyon, Yoshino, Ichiro, Nakajima, Jun, Ikeda, Norihiko, Matsuguma, Haruhisa, Iwata, Takekazu, Shintani, Yasushi, Nakayama, Mitsuo, Oyama, Takahiko, Chida, Masayuki, Kuroda, Hiroaki, Hashimoto, Hiroshi, Azuma, Yoko, Funai, Kazuhito, Endoh, Makoto, Uemura, Yukari, and Kawamura, Masafumi

Published
2023
Full Text
View/download PDF

30. Supplementary Figure 1 from FBXW7 Mediates Chemotherapeutic Sensitivity and Prognosis in NSCLCs

Author

Yokobori, Takehiko, primary, Yokoyama, Yozo, primary, Mogi, Akira, primary, Endoh, Hideki, primary, Altan, Bolag, primary, Kosaka, Takayuki, primary, Yamaki, Ei, primary, Yajima, Toshiki, primary, Tomizawa, Kenji, primary, Azuma, Yoko, primary, Onozato, Ryoichi, primary, Miyazaki, Tatsuya, primary, Tanaka, Shigebumi, primary, and Kuwano, Hiroyuki, primary

Published
2023
Full Text
View/download PDF

31. Supplementary Tables 1 and 2 from FBXW7 Mediates Chemotherapeutic Sensitivity and Prognosis in NSCLCs

Author

Yokobori, Takehiko, primary, Yokoyama, Yozo, primary, Mogi, Akira, primary, Endoh, Hideki, primary, Altan, Bolag, primary, Kosaka, Takayuki, primary, Yamaki, Ei, primary, Yajima, Toshiki, primary, Tomizawa, Kenji, primary, Azuma, Yoko, primary, Onozato, Ryoichi, primary, Miyazaki, Tatsuya, primary, Tanaka, Shigebumi, primary, and Kuwano, Hiroyuki, primary

Published
2023
Full Text
View/download PDF

32. Data from FBXW7 Mediates Chemotherapeutic Sensitivity and Prognosis in NSCLCs

Author

Yokobori, Takehiko, primary, Yokoyama, Yozo, primary, Mogi, Akira, primary, Endoh, Hideki, primary, Altan, Bolag, primary, Kosaka, Takayuki, primary, Yamaki, Ei, primary, Yajima, Toshiki, primary, Tomizawa, Kenji, primary, Azuma, Yoko, primary, Onozato, Ryoichi, primary, Miyazaki, Tatsuya, primary, Tanaka, Shigebumi, primary, and Kuwano, Hiroyuki, primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure 2 from FBXW7 Mediates Chemotherapeutic Sensitivity and Prognosis in NSCLCs

Author

Yokobori, Takehiko, primary, Yokoyama, Yozo, primary, Mogi, Akira, primary, Endoh, Hideki, primary, Altan, Bolag, primary, Kosaka, Takayuki, primary, Yamaki, Ei, primary, Yajima, Toshiki, primary, Tomizawa, Kenji, primary, Azuma, Yoko, primary, Onozato, Ryoichi, primary, Miyazaki, Tatsuya, primary, Tanaka, Shigebumi, primary, and Kuwano, Hiroyuki, primary

Published
2023
Full Text
View/download PDF

34. Supplementary Figure Legend from FBXW7 Mediates Chemotherapeutic Sensitivity and Prognosis in NSCLCs

Author

Yokobori, Takehiko, primary, Yokoyama, Yozo, primary, Mogi, Akira, primary, Endoh, Hideki, primary, Altan, Bolag, primary, Kosaka, Takayuki, primary, Yamaki, Ei, primary, Yajima, Toshiki, primary, Tomizawa, Kenji, primary, Azuma, Yoko, primary, Onozato, Ryoichi, primary, Miyazaki, Tatsuya, primary, Tanaka, Shigebumi, primary, and Kuwano, Hiroyuki, primary

Published
2023
Full Text
View/download PDF

35. Survival after Lung Metastasectomy from Esophageal Cancer: Results from a Multi-Institutional Database

Author

Yamauchi, Yoshikane, Nakajima, Jun, Mun, Mingyon, Shintani, Yasushi, Kuroda, Hiroaki, Iwata, Takekazu, Endo, Makoto, Azuma, Yoko, Chida, Masayuki, Sakao, Yukinori, Yoshino, Ichiro, Ikeda, Norihiko, Matsuguma, Haruhisa, Funai, Kazuhito, Hashimoto, Hiroshi, Kawamura, Masafumi, and Japan, on behalf of the Metastatic Lung Tumor Study Group of Japan on behalf of the Metastatic Lung Tumor Study Group of

Subjects
Cancer Research, Oncology, lung metastasis, esophageal cancer, prognostic factor, pulmonary metastasectomy
Abstract

To clarify the clinical impact and to identify prognostic predictors of surgical intervention for pulmonary metastasis from esophageal cancer, a registry database analysis was performed. From January 2000 to March 2020, patients who underwent resection of pulmonary metastases from primary esophageal cancer at 18 institutions were registered in a database developed by the Metastatic Lung Tumor Study Group of Japan. An amount of 109 cases were reviewed and examined for the prognostic factors for pulmonary metastasectomy of metastases from esophageal cancer. As a result, five-year overall survival after pulmonary metastasectomy was 34.4% and five-year disease-free survival was 22.1%. The multivariate analysis for overall survival revealed that initial recurrence site, maximum tumor size, and duration from primary tumor treatment to lung surgery were selected as the significant prognostic factors (p = 0.043, p = 0.048, and p = 0.037, respectively). In addition, from the results of the multivariate analysis for disease free survival, number of lung metastases, initial recurrence site, duration from primary tumor treatment to lung surgery, and preoperative chemotherapy for lung metastasis were selected as the significant prognostic factors (p = 0.037, p = 0.008, p = 0.010, and p = 0.020, respectively). In conclusion, eligible patients with pulmonary metastasis from esophageal cancer selected based on the identified prognostic predictors would be good candidates for pulmonary metastasectomy.

Published
2023
Full Text
View/download PDF

42. Field carcinogenesis and biological significance of the potential of the bystander effect: carcinogenesis, therapeutic response, and tissue regeneration

Author

Kuwano, Hiroyuki, primary, Yokobori, Takehiko, additional, Miyazaki, Tatsuya, additional, Sohda, Makoto, additional, Yoshida, Tomonori, additional, Azuma, Yoko, additional, Tatsuki, Hironori, additional, Ubukata, Yasunari, additional, Nakazawa, Nobuhiro, additional, Kuriyama, Kengo, additional, Sano, Akihiko, additional, Sakai, Makoto, additional, Ogawa, Hiroomi, additional, Saeki, Hiroshi, additional, and Shirabe, Ken, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results